v3.26.1
Consolidated Statement of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Cash Flows from Operating Activities:    
Net loss $ (30,410,422) $ (14,349,996)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation 4,980,139 4,730,355
Loss on issuance of senior secured convertible note and warrants 128,836,250
Change on fair value of convertible note and warrants (31,163,415)
Gain on settlement of incremental warrants (82,299,000)
Amortization and depreciation 687,719 1,018,934
Amortization of right-of-use assets 588,914 561,654
Change in fair value of derivatives (899,874) 1,338,506
Amortization of debt discount and financing fees 63,160 649,138
(Gain) loss on extinguishment of debt (3,961,075) 777,558
Impairment of goodwill and intangibles 6,911,770 787,438
Non-cash interest expense 218,049 8,793
Allowance for credit losses 13,139 82,324
Changes in Operating Assets and Liabilities:    
Accounts receivable (333,929) (174,175)
Other assets (24,849) 15,387
Accounts payable 867,476 1,131,817
Accrued expenses (872,247) 459,952
Contract liabilities 163,353 7,747
Security deposits and escrow payable (320,204) 524,854
Operating lease liabilities (573,813) (567,593)
Net Cash Used in Operating Activities (7,528,859) (2,997,307)
Cash Flows from Investing Activities:    
Purchase of property plant and equipment (5,033)
Cash acquired through acquisition of businesses (63,592)
Net Cash Provided by Investing Activities (68,625)
Cash Flows from Financing Activities:    
Borrowings on bank line of credit 6,898 300,508
Payments on bank line of credit (155,874) (151,532)
Proceeds from notes payable 3,408,585 3,363,228
Payments of deferred debt issuance costs (138,895) (459,094)
Payments on notes payable (420,778) (1,027,522)
Proceeds from advances on future receipts 1,899,250
Payments on advances on future receipts (694,871) (1,121,368)
Payments on post-acquisition consideration (384,354) (150,000)
Distributions to noncontrolling interest (1,377,484)
Repurchase of derivative instruments issued (379,083)
Proceeds from issuance of common stock 7,610,896 2,928,685
Withholding tax paid on behalf of employees on stock-based awards (1,958)
Net Cash Provided by Financing Activities 8,852,524 4,202,713
Net Increase in Cash, Cash equivalents and Restricted Cash 1,323,665 1,136,781
Cash, Cash equivalents and Restricted Cash at Beginning of Period 3,580,608 2,443,827
Cash, Cash equivalents and Restricted Cash at End of Period 4,904,273 3,580,608
Cash Paid During the Period for:    
Interest 291,566 335,425
Non-Cash Activities    
Issuance of Series B in exchange of incremental warrants 8,261,000
Issuance of new convertible note 8,364,000
Issuance of 282 shares of common stock as part of the settlement of notes payable and warrants 812,153
Issuance of 4,629 shares of common stock for services rendered 4,980,139
Issuance of 8,965 shares of common stock for conversion of liabilities 2,222,563
Office leases acquired under operating lease obligations 555,190 883,652
Reclassification of non-contingent portion of Series X redemption price 2,000,000
Derivative liability embedded in debt instruments 269,038
Issuance of 356 shares of common stock as consideration of acquisitions of businesses 3,601,272
Issuance of 49 shares of common stock as consideration of acquisitions of remaining non-controlling interest 377,485
Issuance of 145 shares of common stock as part of the issuance of notes payable 1,076,768
Issuance of 189 shares of common stock for services rendered 4,730,355
Issuance of 30 shares of common stock for accounts payable 150,000
Reconciliation of Cash, Cash equivalents and Restricted Cash    
Cash and Cash equivalents 3,086,770 1,442,901
Restricted Cash 1,817,503 2,137,707
Cash, Cash equivalents and Restricted Cash $ 4,904,273 $ 3,580,608